Amplitude Vascular Systems’ $835M Acquisition by Stryker

 BioStar Capital, a venture capital firm focused on transformative medical technologies, has announced a landmark pre-FDA exit of Amplitude Vascular Systems, Inc. (AVS), a medical technology company that created a next-generation hydraulic intravascular lithotripsy (IVL) platform to treat calcified peripheral arterial disease. Upon acquiring AVS for up to $835 million, Stryker (NYSE:SYK), a global leader in medical technologies, called the deal a milestone in the expansion of its peripheral vascular portfolio.

https://www.businesswire.com/news/home/20260519752884/en/BioStar-Capital-Backed-Amplitude-Vascular-Systems-%24835M-Acquisition-by-Stryker-Reflects-Strength-of-Michigans-Medtech-Ecosystem